FDAClass IIMay 1, 2024

Biomet OrthoPak Non-invasive Bone Growth Stimulator recall

Biomet OrthoPak Non-invasive Bone Growth Stimulator System-Indicated for the treatment of an established nonunion acquired secondary to trauma…

Why was Biomet OrthoPak Non-invasive Bone Growth Stimulator recalled?

Damage to the lead wire sheath (black cable) component and causing exposure of the wires, potentially lead to no therapeutic treatment signal being delivered to the electrodes, and result in delay of treatment

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

UD-DI: 00812301020232 All devices distributed since May 1, 2023

Product
Biomet OrthoPak Non-invasive Bone Growth Stimulator System-Indicated for the treatment of an established nonunion acquired secondary to trauma…
Recalling firm
EBI, LLC
Quantity
1412 units ( 2 leads per assembly)
Distribution
US Nationwide distribution.
Recall date
May 1, 2024
Classification
Class II
Status
Ongoing
Agency
FDA (device)
Open FDA enforcement record Latest recalls